HIGHLIGHTS
- who: Vivek Narayan and Eric Jonasch from the Division of Hematology/Medical Oncology, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, USA have published the Article: Systemic Therapy Development in Von Hippel-Lindau Disease: An Outsized Contribution from an Orphan Disease, in the Journal: Cancers 2022, 14, 5313. of /2022/
- what: The aim was to evaluate the safety of sunitinib, and the secondary objectives included efficacy evaluation assessed by radiographic response. Co-primary endpoints of the study were safety and objective response rate.
- future: Future Directions for Systemic Therapy in VHL Disease
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.